LGD-4033 (VK5211, Ligandrol) was developed to treat muscle wasting and osteoporosis. It is a nonsteroidal, oral selective androgen receptor modulator which binds to the androgen receptor with high affinity and selectivity.Test results have shown increased lean body mass and decreased body fat. It has also shown significant increase in strength, well-being and healing properties.
LGD-4033 has similar effects to anabolics with size and strength with minimal side effects. It works well alone or stacked with other SARMs. It has a half-life of 24 to36 hours.
*Everything in this description is publicly available and is intended for informational purposes only. For more detailed information, please conduct your own research and consult with experts in the field.